13F Holdings
中文EN

ITGR Integer Holdings Corp

Electromedical & Electrotherapeutic Apparatus · NYSE · SEC CIK 1114483 · Fiscal year ends 12/31

Financial factors as of 2026-10-02 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.3%
TTM net income YoY19.3%
TTM EPS YoY22.7%
Revenue 3-yr CAGR5.6%
Net income 3-yr CAGR8.0%

Margins

Gross margin24.6%
Operating margin8.2%
Net margin5.7%
FCF margin4.5%
EBITDA margin15.9%

Returns

ROE6.0%
ROA3.1%
ROIC (approx.)5.0%
Asset turnover0.54x

Leverage & solvency

Liabilities / assets49.1%
Debt / equity0.71x
Current ratio3.98x
Interest coverage3.87x

Cash quality & payout

Operating cash flow / net income1.70x
Accruals ratio-2.1%
Payout ratio—
Capex / revenue5.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$1.85B$1.72B$1.56B$1.33B$1.22B
Cost of revenue$1.35B$1.26B$1.15B$985.52M$884.11M
Gross profit$500.39M$459.01M$409.89M$345.76M$336.97M
R&D expense$49.50M$53.42M$61.97M$59.76M$51.98M
SG&A expense$211.75M$185.20M$173.17M$158.05M$141.42M
Operating income$221.26M$208.24M$163.32M$112.68M$135.71M
Interest expense$43.21M$56.37M$51.27M$37.27M$31.63M
Pretax income$125.40M$147.56M$105.38M$68.68M$101.06M
Income tax$22.57M$26.51M$16.24M$8.93M$8.04M
Net income$102.81M$119.90M$90.65M$66.38M$96.81M
EBITDA$351.93M$319.27M$262.16M$204.67M$217.08M
EPS (basic)2.963.572.722.002.93
EPS (diluted)2.893.362.691.992.91
Weighted avg. shares (diluted)35.59M35.65M33.76M33.36M33.26M
Balance sheet
Cash & equivalents$17.16M$46.54M$23.67M$24.27M$17.89M
Receivables$346.08M$245.27M$231.28M$224.32M$182.31M
Inventory$253.74M$247.13M$229.10M$208.77M$155.70M
Current assets$770.10M$671.12M$617.67M$558.30M$452.98M
PP&E, net$536.43M$465.80M$392.57M$317.24M$277.10M
Goodwill$1.11B$1.02B$994.01M$965.19M$924.70M
Intangibles$825.43M$778.29M$779.60M$819.89M$807.81M
Total assets$3.41B$3.08B$2.94B$2.79B$2.58B
Current liabilities$232.04M$227.17M$220.97M$223.75M$159.63M
Short-term debt$0$10.00M$0$18.19M$15.25M
Long-term debt$1.19B$980.15M$959.92M$907.07M$812.88M
Total debt$1.19B$990.15M$959.92M$925.26M$828.13M
Total liabilities$1.66B$1.46B$1.42B$1.38B$1.23B
Shareholders' equity$1.75B$1.62B$1.52B$1.42B$1.35B
Net debt$1.17B$943.61M$936.25M$900.99M$810.24M
Shares outstanding34.35M33.55M33.33M33.17M33.06M
Cash flow statement
Operating cash flow$196.15M$205.21M$180.21M$116.38M$156.67M
Capital expenditure$91.03M$105.36M$119.94M$74.73M$53.46M
Free cash flow$105.12M$99.85M$60.27M$41.65M$103.20M
Investing cash flow-$270.73M-$195.41M-$163.37M-$200.42M-$271.00M
Financing cash flow$43.56M$13.32M-$18.01M$92.48M$81.99M
Depreciation & amortization$130.67M$111.03M$98.84M$91.99M$81.37M
Stock-based compensation$23.22M$24.77M$23.28M$21.02M$16.18M
Share buybacks$50.01M$0$0——

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.